Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action

– IMU-856 is an Orally Available, Systemically Acting, Highly Selective and Potent Small Molecule Modulator of SIRT6 – – Targets Regeneration of Bowel Epithelium and Restoration of Intestinal Barrier Function – – Builds on Recently Released Phase 1b Data Showing Beneficial Effects in…